Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huatuo Zaizao is a Traditional Chinese Medicine (TCM) herbal formula primarily used for the treatment and rehabilitation of ischemic stroke. Developed and manufactured by Guangzhou Baiyunshan Zhongyi Pharmaceutical, it is composed of multiple botanical ingredients including *Ligusticum chuanxiong*, *Evodia rutaecarpa*, and *Panax ginseng*. The formula is designed to promote blood circulation, resolve blood stasis, and improve neurological recovery. Clinical studies, including Phase 4 trials, have evaluated its efficacy in improving motor function and neurological deficits in patients during both the acute and recovery stages of stroke. Its pharmacological mechanism is thought to involve neuroprotective effects, anti-inflammatory activity, and the modulation of cerebral blood flow.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huatuo Zaizao.